Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Appointments

Executives On The Move: New CEOs at RhoVac and Step Pharma

Recent appointments at executive level in pharmaceutical and biotech companies include new CEOs at RhoVac AB, Step Pharma and Ascendis Health, a new chief business officer at MaaT Pharma, and a new chief scientific officer at Pieris Pharmaceuticals.


Appointments BioPharmaceutical

Executives On The Move: Bayer Acquires Talent from J&J And Synlogic And Stealth Decide On Chief Positions

Former J&J exec joins Bayer AG as head, business development and licensing. Synthetic biotic medicines firm Synlogic welcomes a CMO and Stealth BioTherapeutics, which is developing candidates for treatment of mitochondrial dysfunction, adds a CFO.

Appointments BioPharmaceutical

Executives On The Move: Management Changes In Quality, Tech And Finance At Eisai, Frequency Therapeutics And Fresenius

Japanese pharma Eisai picks Merck Research exec as VP, Global Clinical Quality Assurance and former Moderna scientist joins regenerative med company Frequency Therapeutics in SVP, Technology Development slot.  Meanwhile, Fresenius Medical Care announces CFO hire.

Appointments BioPharmaceutical

Executives On The Move: Exits Are In the News This Week From Bristol-Myers Squibb, Glenmark And EMD Serono

Daiichi Sankyo appoints former Bristol-Myers Squibb global head of talent as its chief people officer and Glenmark CMO switches to same position at cellular medicines firm Mesoblast Ltd. At GlaxoSmithKline, an EMD Serono SVP will be president, US Pharma.

Appointments BioPharmaceutical

Executives On The Move: Top Hires At Ribon And SQZ And Roche Promotes A Business Leader

Ribon Therapeutics, developer of new cancer medicines, chooses a CBO and former Merck & Co. SVP joins cellular therapies firm SQZ Biotech. Meanwhile, Roche promotes global diagnostics VP to President, Roche Diagnostics Canada.

Appointments BioPharmaceutical

Executives On The Move: Kite Pharma Announces Its Next CEO And A Trio Of VPs For Tilray

T-cell therapy firm Kite Pharma announces a former Eli Lilly VP as its next CEO. Over at Canadian pharma and cannabis business Tilray, three new VPs for Europe in expansion, marketing and commercial development.

Appointments BioPharmaceutical

Executives On The Move: EIP Pharma Acquires Talent From Shire, And Arvinas And Selvita Fill Top Medical Spots

CNS-focused therapeutics developer EIP Pharma adds former Shire VP as CFO. And new CMOs for protein-degradation therapeutics firm Arvinas and European drug discovery business Selvita.

Appointments BioPharmaceutical

Asia Executives On The Move: Returners And Leavers At Merck; Changes At Takeda, Ono, Simcere And More

Merck China former R&D head returns after a short stint with startup Ascletis, and Takeda has a new center director for commercial health. Top executives change also take place at Ono in Korea and Simcere Pharma.

Asia Pacific Appointments

Executives On The Move: Amgen Biologics Head Joins Immusoft; Julphar Poaches From Novartis, AbbVie And Mylan

New CSOs for Immusoft, Julphar Gulf Pharmaceutical Industries and CMOs for Idera Pharmaceuticals, ImCheck Therapeutics, Iovance Biotherapeutics and 2cureX are among the latest industry appointments.
Appointments BioPharmaceutical

Executives On The Move: Exits At AbbVie And Shire Pharma, And A Regional Leadership Appointment At Acino

AbbVie medical exec now holds CMO position at vaccines company Vaccitech, and Shire Pharma head of international commercial picked for CEO of protein-misfolding firm Orphazyme. Swiss pharma Acino International appoints former Novartis services head as General Manager, Latin America.

Appointments BioPharmaceutical

Asia Executives On The Move: Changes At Pfizer, Lilly, Alexion, Healios

The coming of summer has brought a flurry of executive changes in the Asia-Pacific health sector. Pfizer China's head of R&D is leaving while Lilly and Alexion in Japan have new presidents.

Appointments China

Executives On The Move: Alnylam Decides On Next CFO, Annexon Picks A CBO And Eli Lilly Announces A New Area President

At Alnylam a new CFO is in place. Annexon Biosciences chooses as CBO a Johnson & Johnson Innovation leader and Eli Lilly & Co promotes exec to SVP and President, Lilly Bio-Medicines.

Appointments BioPharmaceutical
See All